FRA:RHK - DE0007042301 - Common Stock
The current stock price of RHK.DE is 11.9 EUR. In the past month the price decreased by -0.83%. In the past year, price increased by 3.48%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
EMEIS.PA | EMEIS SA | N/A | 1.97B | ||
CLARI.PA | CLARIANE SE | N/A | 1.53B | ||
GDS.PA | RAMSAY GENERALE DE SANTE SA | N/A | 1.10B | ||
GHC.MI | GAROFALO HEALTH CARE SPA | 13.8 | 435.67M | ||
LNA.PA | LNA SANTE | 14.23 | 324.51M | ||
M12.DE | M1 KLINIKEN AG | 16.56 | 266.71M | ||
MED.DE | MEDICLIN AG | 4.37 | 147.25M | ||
LIK.DE | LIMES SCHLOSSKLINIKEN AG | 23.32 | 99.76M | ||
MAK.DE | MATERNUS-KLINIKEN AG | N/A | 24.95M | ||
EIF.DE | MEDNATION AG | 92.5 | 5.77M |
Rhön-Klinikum AG engages in the provision of healthcare services. The company is headquartered in Bad Neustadt An Der Saale, Bayern and currently employs 18,821 full-time employees. The firm operates acute hospitals, medical care centers, and rehabilitation hospitals across Germany: six clinics on Campus Bad Neustadt, including the Cardiovascular Clinic, the Frankenklinik for the Rehabilitation of Cardiovascular Patients, the Clinic for Hand Surgery, the Neurological Clinic, the Psychosomatic clinic and the Saaletalklinik with two additional addiction therapy facilities; Klinikum Frankfurt (Oder) comprises clinics, psychiatric outpatient institutions, and day clinics; University Hospital Giessen and Marburg (UKGM) offers medical services, modern diagnostics and comprehensive therapy in various areas, including ophthalmology, trauma surgery and dentistry, and Zentralklinik Bad Berka provides health care services to patients with thoracic, pulmonary and vascular diseases, tumors, neurological conditions, and diseases of the spinal column, joints and heart, among others.
RHOEN-KLINIKUM AG
Schlossplatz 1
Bad Neustadt an der Saale BAYERN DE
Employees: 18821
Phone: 499771650
The current stock price of RHK.DE is 11.9 EUR. The price decreased by -0.83% in the last trading session.
The exchange symbol of RHOEN-KLINIKUM AG is RHK and it is listed on the Deutsche Boerse Ag exchange.
RHK.DE stock is listed on the Deutsche Boerse Ag exchange.
7 analysts have analysed RHK.DE and the average price target is 14.45 EUR. This implies a price increase of 21.43% is expected in the next year compared to the current price of 11.9. Check the RHOEN-KLINIKUM AG stock analysts ratings, price target forecast and up-and down grades for more detailed information.
RHOEN-KLINIKUM AG (RHK.DE) has a market capitalization of 796.82M EUR. This makes RHK.DE a Small Cap stock.
RHOEN-KLINIKUM AG (RHK.DE) currently has 18821 employees.
RHOEN-KLINIKUM AG (RHK.DE) has a support level at 11.3 and a resistance level at 12.05. Check the full technical report for a detailed analysis of RHK.DE support and resistance levels.
The Revenue of RHOEN-KLINIKUM AG (RHK.DE) is expected to grow by 5.98% in the next year. Check the estimates tab for more information on the RHK.DE EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
RHOEN-KLINIKUM AG (RHK.DE) has a dividend yield of 0.83%. The yearly dividend amount is currently 0. Check the full fundamental report for a detailed analysis of RHK.DE dividend history, reliability and sustainability.
RHOEN-KLINIKUM AG (RHK.DE) will report earnings on 2025-11-06.
The PE ratio for RHOEN-KLINIKUM AG (RHK.DE) is 19.83. This is based on the reported non-GAAP earnings per share of 0.6 and the current share price of 11.9 EUR. Check the full fundamental report for a full analysis of the valuation metrics for RHK.DE.
ChartMill assigns a fundamental rating of 5 / 10 to RHK.DE. RHK.DE is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average.
Over the last trailing twelve months RHK.DE reported a non-GAAP Earnings per Share(EPS) of 0.6. The EPS decreased by -7.07% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 2.72% | ||
ROA | 2.34% | ||
ROE | 3.35% | ||
Debt/Equity | 0.09 |
7 analysts have analysed RHK.DE and the average price target is 14.45 EUR. This implies a price increase of 21.43% is expected in the next year compared to the current price of 11.9.
For the next year, analysts expect an EPS growth of 9.14% and a revenue growth 5.98% for RHK.DE